table of content
1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnostics in Infectious Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnostics in Infectious Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnostics in Infectious Disease Testing Overall Market Size
2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size: 2022 VS 2035
2.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Diagnostics in Infectious Disease Testing Players in Global Market
3.2 Top Global Molecular Diagnostics in Infectious Disease Testing Companies Ranked by Revenue
3.3 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Molecular Diagnostics in Infectious Disease Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Diagnostics in Infectious Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Molecular Diagnostics in Infectious Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Diagnostics in Infectious Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Diagnostics in Infectious Disease Testing Market Size Markets, 2022 & 2035
4.1.2 Polymerase Chain Reaction (PCR)
4.1.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
4.1.4 Microarrays
4.1.5 Next-Generation Sequencing (NGS)
4.1.6 Hybridization
4.1.7 Others
4.2 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2023
4.2.2 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2024-2035
4.2.3 By Type - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Diagnostics in Infectious Disease Testing Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Academic Institutes
5.1.5 Laboratories
5.1.6 Others
5.2 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2023
5.2.2 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2024-2035
5.2.3 By Application - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Molecular Diagnostics in Infectious Disease Testing Market Size, 2022 & 2035
6.2 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2023
6.2.2 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue, 2024-2035
6.2.3 By Region - Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.3.2 US Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.3.3 Canada Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.3.4 Mexico Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.4.2 Germany Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.3 France Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.4 U.K. Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.5 Italy Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.6 Russia Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.7 Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.4.8 Benelux Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.5.2 China Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.3 Japan Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.4 South Korea Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.5 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.5.6 India Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.6.2 Brazil Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.6.3 Argentina Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Revenue, 2018-2035
6.7.2 Turkey Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7.3 Israel Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7.4 Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
6.7.5 UAE Molecular Diagnostics in Infectious Disease Testing Market Size, 2018-2035
7 Molecular Diagnostics in Infectious Disease Testing Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.1.4 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 BD
7.2.1 BD Company Summary
7.2.2 BD Business Overview
7.2.3 BD Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.2.4 BD Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.2.5 BD Key News & Latest Developments
7.3 BioMerieux
7.3.1 BioMerieux Company Summary
7.3.2 BioMerieux Business Overview
7.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.3.4 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.3.5 BioMerieux Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.4.4 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.5.4 Roche Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Siemens
7.6.1 Siemens Company Summary
7.6.2 Siemens Business Overview
7.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.6.4 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.6.5 Siemens Key News & Latest Developments
7.7 Veridex
7.7.1 Veridex Company Summary
7.7.2 Veridex Business Overview
7.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.7.4 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.7.5 Veridex Key News & Latest Developments
7.8 Luminex
7.8.1 Luminex Company Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.8.4 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.8.5 Luminex Key News & Latest Developments
7.9 GenMark Diagnostics
7.9.1 GenMark Diagnostics Company Summary
7.9.2 GenMark Diagnostics Business Overview
7.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.9.4 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.9.5 GenMark Diagnostics Key News & Latest Developments
7.10 Qiagen
7.10.1 Qiagen Company Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.10.4 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.10.5 Qiagen Key News & Latest Developments
7.11 Genomix Biotech
7.11.1 Genomix Biotech Company Summary
7.11.2 Genomix Biotech Business Overview
7.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.11.4 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.11.5 Genomix Biotech Key News & Latest Developments
7.12 BioTheranostics
7.12.1 BioTheranostics Company Summary
7.12.2 BioTheranostics Business Overview
7.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Major Product Offerings
7.12.4 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue in Global Market (2018-2023)
7.12.5 BioTheranostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
